Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pirfenidone by Avalyn Pharma for Pulmonary Fibrosis: Likelihood of Approval
Pirfenidone is under clinical development by Avalyn Pharma and currently in Phase II for Pulmonary Fibrosis. According to GlobalData, Phase...
Data Insights
Nintedanib by Avalyn Pharma for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Likelihood of Approval
Nintedanib is under clinical development by Avalyn Pharma and currently in Phase I for Interstitial Lung Diseases (Diffuse Parenchymal Lung...